日水製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2012/03/23 | 日証協 | 8,700株 | +40.32% | 7,400株 | -35.65% | 63,919株 | +25.25% | 5,704株 | -73.22% |
| 2012/03/16 | 日証協 | 6,200株 | -15.07% | 11,500株 | -25.81% | 51,034株 | +13.58% | 21,300株 | +384.09% |
| 2012/03/09 | 日証協 | 7,300株 | +28.07% | 15,500株 | +118.31% | 44,934株 | +0.45% | 4,400株 | +51.72% |
| 2012/03/02 | 日証協 | 5,700株 | +67.65% | 7,100株 | +446.15% | 44,734株 | -0.22% | 2,900株 | +866.67% |
| 2012/02/24 | 日証協 | 3,400株 | +17.24% | 1,300株 | -53.57% | 44,834株 | -3.03% | 300株 | -78.57% |
| 2012/02/17 | 日証協 | 2,900株 | -12.12% | 2,800株 | -37.78% | 46,234株 | -7.22% | 1,400株 | -57.58% |
| 2012/02/10 | 日証協 | 3,300株 | +32% | 4,500株 | +104.55% | 49,834株 | -2.16% | 3,300株 | -54.79% |
| 2012/02/03 | 日証協 | 2,500株 | -16.67% | 2,200株 | -4.35% | 50,935株 | -5.21% | 7,300株 | +62.22% |
| 2012/01/27 | 日証協 | 3,000株 | -14.29% | 2,300株 | +187.5% | 53,735株 | -3.76% | 4,500株 | +221.43% |
| 2012/01/20 | 日証協 | 3,500株 | +16.67% | 800株 | -52.94% | 55,835株 | -1.76% | 1,400株 | -46.15% |
| 2012/01/13 | 日証協 | 3,000株 | +7.14% | 1,700株 | +70% | 56,835株 | -2.07% | 2,600株 | +420% |
| 2012/01/06 | 日証協 | 2,800株 | 0% | 1,000株 | -50% | 58,035株 | +2.27% | 500株 | -77.28% |
| 2011/12/30 | 日証協 | 2,800株 | +3.7% | 2,000株 | +17.65% | 56,749株 | +1.43% | 2,201株 | -67.18% |
| 2011/12/22 | 日証協 | 2,700株 | +3.85% | 1,700株 | -58.54% | 55,949株 | +1.45% | 6,707株 | +4.8% |
| 2011/12/16 | 日証協 | 2,600株 | 0% | 4,100株 | +36.67% | 55,148株 | +3.79% | 6,400株 | +165.01% |
| 2011/12/09 | 日証協 | 2,600株 | +100% | 3,000株 | +57.89% | 53,133株 | -3.3% | 2,415株 | +20.75% |
| 2011/12/02 | 日証協 | 1,300株 | -18.75% | 1,900株 | +90% | 54,948株 | +2.42% | 2,000株 | -4.76% |
| 2011/11/25 | 日証協 | 1,600株 | +220% | 1,000株 | +66.67% | 53,648株 | +2.29% | 2,100株 | -80.37% |
| 2011/11/18 | 日証協 | 500株 | -16.67% | 600株 | -40% | 52,448株 | +1.75% | 10,700株 | -26.21% |
※株式分割は考慮していませんのでご注意ください。